Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to bupivacaine for postoperative pain after mandibular third molar surgery
IRCT20190819044566N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine, bupivacaine and ibuprofen in postoperative pain (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Pain intensity at 4 hours after surgery, Pain intensity at 8 hours after surgery and 2 more. Started Oct 2019; status: completed.
02
Drugs
dexmedetomidinebupivacaineibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20190819044566N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190819044566N1.